You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 106 No. 6, DECEMBER 1960 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Shock with Sympathicomimetic Drugs

Use of Metaraminol and Comparison with Other Vasopressor Agents

LEWIS C. MILLS, M.D.; IGNATIOS J. VOUDOUKIS, M.D.; JOHN H. MOYER, M.D.; CHARLES HEIDER, M.D.

Arch Intern Med. 1960;106(6):816-823.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Although several vasopressor drugs are available for the treatment of shock, many are characterized by one or more undesirable properties. During the last several years in this hospital most of these agents have been used in patients with shock of various etiologies. These observations indicated that metaraminol was an effective drug for the treatment of shock, and that side-effects were infrequent. Therefore, further laboratory studies were done, and an additional group of 67 patients with shock resulting from various causes were studied.

Methods

In the experimental procedures the following drugs were studied: mephentermine (Wyamine), metaraminol (Aramine), phenylephrine (Neosynephrine), levarterenol (norepinephrine, B.P.; Levophed), epinephrine, and methoxamine (Vasoxyl). Epinephrine was included in these studies only for comparative purposes, since its use in the clinical treatment of hypotensive shock is contraindicated. In the renal studies standard techmiques were used to measure glomerular filtration rate and renal plasma flow.1 Cerebral blood flow was . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia

Department of Internal Medicine, Hahnemann Medical College and Hospital.


Footnotes

Submitted for publication July 20, 1960.

Presented before the Joint Session of the Sections on Internal Medicine and Experimental Medicine and Therapeutics at the 109th Annual Meeting of the American Medical Association, Miami Beach, June 13-17, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1960 American Medical Association. All Rights Reserved.